| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
|
N Engl J Med
|
2003
|
13.29
|
|
2
|
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
|
JAMA
|
2005
|
9.81
|
|
3
|
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
|
N Engl J Med
|
1994
|
9.15
|
|
4
|
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
|
N Engl J Med
|
1994
|
7.96
|
|
5
|
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
|
Lancet
|
2007
|
6.77
|
|
6
|
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
|
Lancet
|
2003
|
4.68
|
|
7
|
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
|
JAMA
|
2005
|
3.06
|
|
8
|
Three-year follow-up after implantation of metallic coronary-artery stents.
|
N Engl J Med
|
1996
|
2.95
|
|
9
|
Late angiographic stent thrombosis (LAST) events with drug-eluting stents.
|
J Am Coll Cardiol
|
2005
|
2.90
|
|
10
|
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.
|
J Am Coll Cardiol
|
1998
|
2.23
|
|
11
|
Molecular basis of restenosis and drug-eluting stents.
|
Circulation
|
2005
|
2.08
|
|
12
|
Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
|
JAMA
|
2004
|
2.02
|
|
13
|
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
|
J Am Coll Cardiol
|
2005
|
2.00
|
|
14
|
Stented segment length as an independent predictor of restenosis.
|
J Am Coll Cardiol
|
1999
|
1.94
|
|
15
|
Predictive factors of restenosis after coronary stent placement.
|
J Am Coll Cardiol
|
1997
|
1.84
|
|
16
|
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.
|
Circulation
|
2004
|
1.72
|
|
17
|
Contemporary stent treatment of coronary bifurcations.
|
J Am Coll Cardiol
|
2005
|
1.70
|
|
18
|
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
|
J Am Coll Cardiol
|
2002
|
1.62
|
|
19
|
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.
|
Circulation
|
2004
|
1.56
|
|
20
|
Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
|
Circulation
|
1998
|
1.56
|
|
21
|
Drug eluting stents: an updated meta-analysis of randomised controlled trials.
|
Heart
|
2005
|
1.45
|
|
22
|
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
|
Circulation
|
2006
|
1.25
|
|
23
|
Coronary in-stent restenosis - predictors, treatment and prevention.
|
Eur Heart J
|
2000
|
1.23
|
|
24
|
The contribution of "mechanical" problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions.
|
Am Heart J
|
2001
|
1.14
|
|
25
|
Predictors of diffuse and aggressive intra-stent restenosis.
|
J Am Coll Cardiol
|
2001
|
1.03
|
|
26
|
Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.
|
Circulation
|
1998
|
1.01
|
|
27
|
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial.
|
Circulation
|
2004
|
0.96
|
|
28
|
Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement.
|
Circulation
|
1999
|
0.95
|
|
29
|
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
|
Circulation
|
2005
|
0.88
|
|
30
|
Intimal hyperplasia regression from 6 to 12 months after stenting.
|
Am J Cardiol
|
2002
|
0.82
|
|
31
|
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
|
Am J Cardiol
|
2005
|
0.77
|
|
32
|
Interprocedural interval as a predictor of stent restenosis after previous coronary angioplasty. The Palmaz-Schatz Stent Investigators.
|
Am J Cardiol
|
1996
|
0.75
|